期刊
JOURNAL OF CONTROLLED RELEASE
卷 74, 期 1-3, 页码 147-158出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0168-3659(01)00330-3
关键词
HPMA copolymers; PK1; ovarian carcinoma; antibody fragments; long-circulating macromolecular therapeutics; combination therapy; photodynamic therapy
资金
- NCI NIH HHS [CA51578, CA88047] Funding Source: Medline
The rationales for the use of water soluble polymers for anticancer drug delivery include: the potential to overcome some forms of multidrug; resistance. preferential accumulation in solid tumors due to enhanced permeability and retention (EPR) effect, biorecognizability. and targetability. The utility of a novel paradigm for the treatment of ovarian carcinoma in an experimental animal model. which combines chemotherapy and photodynamic therapy with polymer-bound anticancer drugs is explained. Research and clinical applications as well as directions for the future development of macromolecular therapeutics are discussed. (C) 2001 Elsevier Science B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据